Winslow Evans & Crocker’s Zymeworks ZYME Stock Holding History

Winslow Evans & Crocker’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$2K	Hold	50	–	–	﹤0.01%	1253
2020 Q3	$2K	Hold	50	–	–	﹤0.01%	1032
2020 Q2	$2K	Hold	50	–	–	﹤0.01%	1066
2020 Q1	$2K	Hold	50	–	–	﹤0.01%	1090
2019 Q4	$4K	Hold	50	–	–	﹤0.01%	1050
2019 Q3	$2K	Hold	50	–	–	﹤0.01%	1119
2019 Q2	$2K	Hold	50	–	–	﹤0.01%	1114
2019 Q1	$2K	Hold	50	–	–	﹤0.01%	1275
2018 Q4	$2K	Hold	50	–	–	﹤0.01%	1066
2018 Q3	$2K	Hold	50	–	–	﹤0.01%	1078
2018 Q2	$2K	Buy	+50	New	+$775	﹤0.01%	1089

Other funds holding ZYME

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Winslow Evans & Crocker's ZYME Position: Q4 2020 in Review

Winslow Evans & Crocker held its Zymeworks (ZYME) position steady in Q4 2020 at 50 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1253.

Winslow Evans & Crocker first reported a position in ZYME in Q2 2018 and has held it in 11 quarters since. The position peaked at $4K in Q4 2019. 138 funds tracked by Wall St. Rank hold ZYME as of Q4 2020.

Winslow Evans & Crocker held 50 shares of Zymeworks worth $2K as of Q4 2020.
Winslow Evans & Crocker left its Zymeworks share count unchanged in Q4 2020.
Zymeworks made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1253 holding.
Winslow Evans & Crocker first reported a position in Zymeworks in Q2 2018 and has held it in 11 quarters since.
Winslow Evans & Crocker's Zymeworks position peaked at $4K in Q4 2019.
138 funds tracked by Wall St. Rank held Zymeworks as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.